Unknown

Dataset Information

0

Engineered T Cell Therapy for Cancer in the Clinic.


ABSTRACT: T cells play a key role in cell-mediated immunity, and strategies to genetically modify T cells, including chimeric antigen receptor (CAR) T cell therapy and T cell receptor (TCR) T cell therapy, have achieved substantial advances in the treatment of malignant tumors. In clinical trials, CAR-T cell and TCR-T cell therapies have produced encouraging clinical outcomes, thereby demonstrating their therapeutic potential in mitigating tumor development. This article summarizes the current applications of CAR-T cell and TCR-T cell therapies in clinical trials worldwide. It is predicted that genetically engineered T cell immunotherapies will become safe, well-tolerated, and effective therapeutics and bring hope to cancer patients.

SUBMITTER: Zhao L 

PROVIDER: S-EPMC6798078 | BioStudies | 2019-01-01

REPOSITORIES: biostudies

Similar Datasets

2017-01-01 | S-EPMC5270315 | BioStudies
2017-01-01 | S-EPMC5752304 | BioStudies
2019-01-01 | S-EPMC6921533 | BioStudies
2019-01-01 | S-EPMC7027847 | BioStudies
2020-01-01 | S-EPMC7066210 | BioStudies
2016-01-01 | S-EPMC5484157 | BioStudies
2018-01-01 | S-EPMC5839763 | BioStudies
2020-01-01 | S-EPMC7647973 | BioStudies
2020-01-01 | S-EPMC7685996 | BioStudies
2021-01-01 | S-EPMC7828372 | BioStudies